The purpose of this study is to describe the concept and experience of using temporary aneurysm sac perfusion with second stage side branch completion, as an adjunct to reduce the risk of severe spinal cord ischemia after branched endovascular repair of thoracoabdominal aortic aneurysms.
INTRODUCTION
Endovascular aortic repair using branched stent grafts (bEVAR) is an additional minimally invasive therapeutic option for patients with thoracoabdominal aneurysms (TAAAs). 1e4 However, perioperative spinal cord ischemia (SCI) with paraplegia or paraparesis is still a severe complication after bEVAR, with an incidence of 0e20%. 5, 6 The risk of SCI increases with the extend of the thoracoabdominal aneurysm, the length of the stent grafts used covering intercostal and lumbar arteries, pre-existing aortic reconstruction of the ascending or descending thoracic aorta, and occlusions of supra-aortic or hypogastric arteries. 7e9 During extended thoracoabdominal aortic repair for TAAA the reduction of spinal cord perfusion seems to be mediated by occlusion of the intercostal and lumbar arteries at the proximal and distal landing zones immediately after stent graft implantation and as a secondary effect by progressive thrombosis of the aneurysm sac, causing early or delayed SCI, even after 24e72 h. 10, 11 Spinal cord perfusion is mediated by posterior intercostal and lumbar arteries predominantly at the level of Th8eL2 with further blood supply provided by branches of the left subclavian and vertebral artery, and by both hypogastric arteries. 12, 13 Recent reports indicate that regulation of spinal cord perfusion is mediated by a collateral spinal network represented by paraspinous arterial collaterals, segmental spinal arteries, and dorsal branches of posterior intercostal and lumbar arteries.
14 Furthermore, based on experimental and clinical studies staged interventions with two-step coverage or ligation of thoracic intercostals and lumbar arteries had lower rates of SCI, probably caused by expansion of a pre-existing collateral network or newly formed vessels leading to maintenance of spinal cord perfusion. 15, 16 The concept of temporary aneurysm sac perfusion (TASP) is based on the hypothesis that non-completion of at least one stent graft side branch is expected to prevent complete aneurysm sac thrombosis and maintain spinal cord perfusion through patent intercostal and/or lumbar arteries with the intention of reducing the risk of SCI after bEVAR. The idea of temporary aneurysm sac perfusion has so far been reported in two case reports and a small patient series with either induction of an endoleak after the appearance of SCI in one patient or by using specifically constructed stent grafts with upward and downward directed additional side branches facilitating aneurysm sac perfusion. In this report, early experience using standard or custommade branched endografts for the treatment of TAAA with TASP and staged completion of organ perfusing side branches to reduce the risk of SCI is reported.
METHODS

Study design
In this single centre study feasibility and early perioperative outcome using the concept of TASP was evaluated in patients with TAAA receiving bEVAR between January 2009 and September 2012 compared with patients having bEVAR with immediate side branch completion (non-TASP). The first patient was treated with bEVAR and TASP in January 2008 with non-completion of the right stenotic renal artery and the clinical observation that this patient almost completely recovered from paraplegia within few weeks. The TASP concept was used from January 2009 as an additional adjunct to cerebrospinal fluid (CSF) drainage and maintenance of stable hemodynamics, and recommended for every patient receiving bEVAR for TAAA, except for those having contraindications for side branch non-completion, as described later in the section "TASP" or those refusing a secondary intervention for side branch completion.
Patients
Patients with a TAAA >5.5 cm, rapid aneurysm progression of >5 mm within 6 months, or symptomatic patients were included. Patients with ruptured aneurysms were excluded. Every patient was discussed by the institutional vascular review board and informed consent was obtained from each patient after detailed explanation of the risks and possible benefits. The annual number of patients treated with TASP or without TASP (non-TASP) is shown in Fig. 1 .
Patients with Crawford type I aneurysms were treated as Crawford type II aneurysms because the distal stent graft landing zone was usually in the infrarenal aortic segment.
Endovascular technique
Standard design or custom-made branched aortic endografts were individually planned in cooperation with Cook Planning Center, Perth, Australia and London, UK, and constructed by Cook Endovascular Laboratory (Brisbane, Australia). Endovascular aortic interventions were performed using a mobile C-arm (OEC 9900 Elite; GE, Paris, France) or in a Hybrid operating room (Philips, Allura Xper FD 20; Philips Healthcare, DA Best, the Netherlands). For side branch organ perfusion Advanta V12 (Atrium Medical, Hudson, NH, USA) or Fluency plus (C.R. Bard, Angiomed, Karlsruhe, Germany) stent grafts were used. Visceral stent grafts were aligned using uncovered stents (Wallstent, Boston Scientific, Natick, MA, USA; or Zilver Flex, Cook Medical, Bloomington, IN, USA). Ten patients had endografts with both fenestrations and branches: three patients with three fenestrations and eight branches in the non-TASP group, and seven patients with 16 fenestrations and 12 branches in the TASP group. For all patients CSF drainage was intended and strict perioperative prevention of hypotension was part of the perioperative management.
TASP
For TASP preferentially the celiac trunk was left noncompleted after uncomplicated superior mesenteric artery (SMA) and renal artery stent graft implantation. Other options for side branch non-completion were side branches to an accessory renal artery; a pre-existing high-grade stenotic renal artery with a hypoplastic kidney; a patent inferior mesenteric artery; a solitary hepatic or splenic artery, with an arterial diameter >4 mm for all arteries mentioned before; or non-completion of an aortoiliac stent graft extension in patients treated with a bifurcated stent graft. Contraindications for non-completion of the celiac trunk were complications during side branch stent grafting of the SMA with local dissection of the main SMA branch or loss of distal arterial segments of the SMA. Post-nephrectomy status or reduced renal function with a glomerular filtration rate <30 mL/min excluded non-completion of the remaining, or one of the renal arteries and pre-existing high-grade arteriosclerotic stenosis of the iliofemoral arteries was an argument against non-completion of one of the aortoiliac stent graft extensions. Secondary TASP side branch completion was recommended within 4 weeks of the initial bEVAR, and all patients with symptomatic TAAA had primary side branch completion.
Endpoints of the study
Primary endpoints included overall technical success, perioperative mortality, and freedom from severe SCI after 30 days or at discharge. Secondary endpoints were the rate of early reinterventions, reno-visceral organ dysfunction and any neurological event other than severe SCI. Overall technical success according to the TASP concept was defined as bEVAR, patent TASP side branch or aortoiliac extension, absence of persistent and non-intended type I or type III endoleak, and secondary TASP side branch completion. Type II or type IV endoleaks were not considered for evaluation of technical success.
Neurological evaluation
Neurological evaluation of symptoms related to SCI were classified according to the modified Tarlov paraplegia scoring scale (0e5), focusing on the description of deficits of motor neuron function. 20, 21 The description of the elements of the modified Tarlov scoring scale is shown in Table 1 . Modified Tarlov scales (0e2) were considered for classification of severe SCI in the present study.
Analysis of patent intercostal and lumbar arteries
Patent intercostal and lumbar arteries visible on computed tomographic angiogram (CTA) were counted in each patient from the level of the left subclavian artery to the aortic bifurcation. The assessment was performed twice in every patient by two different investigators (G.C. and R.K.) and calculated for the non-TASP and TASP group before the endovascular treatment, and before and after secondary side branch completion in the TASP group.
Postoperative evaluation
Postoperative evaluation included B-mode and cw-duplex sonography, abdominal radiography in four planes, CTA, and contrast-enhanced ultrasonography usually performed within 3e5 days of the endovascular procedure, before and after secondary side branch completion, after 6 months, and then at yearly intervals or in any case of suspected organ malperfusion or dysfunction. Duplex and contrastenhanced ultrasonography were used postoperatively to differentiate between intended TASP side branch perfusion and non-intended type I or III endoleaks, especially in patients with acute or chronic renal failure. 22 
Data collection and statistical analysis
Data were collected prospectively in an institutional database and analyzed retrospectively. Data were analyzed using SPSS version 20.0 (IBM, Armonk, NY, USA). Descriptive data Walking with some leg and hip instability, mostly without assistance, and with bowel and bladder control 5
Almost normal muscle motor function, walking with minor hip instability, normal sphincter function 
RESULTS
Branched EVAR for TAAA
Endovascular exclusion of thoracoabdominal aneurysms was performed in 83 patients using branched endografts. TASP was performed in 40 patients versus 43 patients receiving bEVAR without TASP (non-TASP). The characteristics of patients and thoracoabdominal aneurysms treated are shown in Table 2 . Branched endografts implanted for endovascular TAAA repair had a mean of 3.6 side branches per patient (range 1e6) with an overall perioperative patency rate of 95%. Ten patients had endografts with both fenestrations and branches. CSF pressure was measured in 79/83 (95%) patients and kept <10 mmHg during the intervention and the first 3e5 postoperative days.
TASP side branches
Temporary aneurysm sac perfusion was performed by noncompletion of the side branches to the celiac trunk (n ¼ 20; 50%), the renal arteries (n ¼ 9; 23%), inferior mesenteric or separate hepatic artery (n ¼ 2; 5%) or distal aortic or iliac extensions (n ¼ 9, 23%; Table 3) 
TASP interval and secondary side branch completion
The time interval between initial implantation of branched endograft with TASP and secondary side branch completion or iliac extension was a median of 48.0 days (mean 60.7 AE 12.9 days) with a wide range (1e370) ) . During the TASP interval, no major adverse embolic events involving the function of liver, intestine, or the lower extremities were observed. However, one patient presented 4 months after the primary bEVAR with episodes of hemoptysis, suggesting an aortobronchial fistula (initial aneurysm diameter 5.6 cm) and died just before the intended side branch completion. Unfortunately, the patient was not readmitted to the hospital and no autopsy was performed. In 8 patients (22.8%) secondary side branch completion was performed under local anesthesia.
Aneurysm sac perfusion and patent intercostal and lumbar arteries
During the TASP interval, visible perfusion of the aneurysm sac was detected in 34/35 patients (97%), as evaluated by CTA performed 3e5 days after bEVAR. The numbers of intercostal and lumbar arteries before bEVAR were 19.0 AE 4.2 in the non-TASP and 17.1 AE 5.0 in the TASP group and not related to severe SCI. Analysis of persistent type II endoleaks visible on CTA after bEVAR and secondary side branch completion showed no difference between the non-TASP (5/43) and TASP group (6/40) and no correlation with paraplegia. As a trend, more patent intercostal and lumbar arteries within the TASP group were detected at the end of the TASP interval when compared with the arteries visible 
Overall technical success and risk of rupture
Five of 40 patients (13%) did not receive secondary completion of the TASP side branch. Two patients died after the initial bEVAR implantation from cerebral infarction or malignant disease. One patient denied side branch completion because of aneurysm regression, in one patient cannulation of the right renal artery failed during two attempts and, as mentioned before, one patient died during the TASP interval. Two of these five patients required early revascularization of the renal or superior mesenteric arteries. Overall technical success, including aneurysm exclusion with bEVAR, intended side branch TASP, absence of persistent and nonintended type I or III endoleak, and secondary side branch completion, was 35/40 patients (88%).
In 5/19 (26%) patients with a TASP interval >4 weeks a relevant progression (!5e16%) of their aneurysm diameter was observed, all of them were asymptomatic. As already mentioned, one patient died 4 months after bEVAR and TASP from suspected aneurysm rupture. Therefore, the risk of rupture during the TASP interval was 1/40 (3%) for all TASP patients and 1/19 (5%) among the patients with secondary side branch completion later than 4 weeks.
Early endovascular reinterventions and organ dysfunction
Early side branch reinterventions were performed for 11/ 306 (4%) branches in eight patients (10%) for high grade stenosis and kinking (n ¼ 8, 3%) or type I or III endoleak (n ¼ 3, 1%) with 3/43 (7%) and 5/40 (13%) patients in the non-TASP and TASP group (Table 4) . Reinterventions for intended secondary side branch occlusion in the TASP group are not included. Two patients (2%) initially received an additional reno-visceral bypass to renal and hepatic arteries by open surgery for renal and hepatic malperfusion; both patients died. Three patients newly required dialysis (8%) with renal side branches occluded perioperatively in addition to pre-existing occlusions of the contralateral renal artery in two patients and progressive renal failure in one patient.
Perioperative mortality
Perioperative 30-day mortality was similar in both groups, 3/43 (7%) in the non-TASP group and 3/40 (8%; Table 4) in the TASP group. Causes of death were intestinal ischemia (n ¼ 3), multi-organ failure after multiple abdominal embolic arterial occlusions (n ¼ 1), hemorrhage after intraarterial lysis for reno-visceral embolisation (n ¼ 1), and a coagulation disorder with intracerebral hemorrhage in another patient. Perioperative and short-term mortality in TASP patients with inclusion of the reported mortality during the TASP interval was 4/40 (10%).
Neurologic complications
Severe SCI was observed in the non-TASP group immediately after the intervention in six patients and delayed in one patient after 24e72 h. Within the TASP group, one patient treated for a Crawford type III aneurysm developed paraplegia immediately after bEVAR, while another developed paraplegia after the secondary side branch completion after 2 months. These patients are included in the analysis as severe SCI. In two patients with severe SCI, CSF drains were reinserted to reduce spinal pressure and when not initially accepted by the patient.
Intention-to-treat analysis of neurological adverse events after the implantation of branched aortic stent grafts after 30 days or at discharge in the non-TASP or TASP group included one versus two perioperative strokes, one versus five paresthesias, one versus five temporary paraparesis, and nine versus two patients with paraplegia (p ¼ .03). Within the subgroup of Crawford type I-III aneurysms the difference between the non-TASP and TASP group regarding severe SCI was even more evident (7/24 vs. 1/29; p ¼ .01; Table 5 ). Similar results were obtained when only those TASP patients were analyzed, having received secondary side branch completion (n ¼ 35, p ¼ 0.02 and n ¼ 26, p > 0.01 in Crawford I-III patients), according to an astreated analysis.
DISCUSSION
This study evaluated the concept of TASP to maintain spinal cord perfusion with the intention of reducing the risk of SCI during bEVAR for TAAA. Based on the findings presented, the described TASP concept is feasible and seems to reduce the risk of severe SCI in patients with thoracoabdominal bEVAR. At the end of the study period almost all patients treated for TAAA received a staged TASP procedure. However, the risk of aneurysm rupture during the TASP interval has to be considered and, based on our experience, early side branch completion within 4 weeks is recommended according to the presence or absence of symptoms of SCI.
Overall post-interventional neurological complications were observed in both groups, but patients in the TASP group had less severe neurological deficits and recovered more rapidly within 30 days or by discharge. These findings might support the concept of TASP with continued blood flow to intercostal and lumbar arteries to maintain residual spinal cord perfusion. 18, 19 However, one patient had severe SCI after secondary side branch completion after 2 months. Therefore, it remains unclear if the TASP concept will prevent late severe SCI weeks or months after secondary side branch occlusion, probably in patients with insufficient expansion of the spinal cord collateral network. Therefore, CSF drainage, normal hemoglobin levels and prevention of hypotension are still the most crucial elements for perioperative management of patients treated for TAAA to reduce the risk of SCI. 21 Three patients in the TASP group had supra-aortic embolic events. So far, our results do not indicate an association between adverse cerebrovascular embolic events and the usual left transaxillary access for secondary TASP side branch completion. In addition, the characteristics of the patients in the TASP group already indicate a higher incidence of cerebrovascular events and stroke in their past medical history.
Technical modifications of the branched stent grafts might further improve the results obtained so far. However, all but one non-completed side branches, located on the front side of the stent graft for the celiac trunk or laterally for the renal arteries, remained open during the TASP interval. It might be more physiological to position these side branches proximal and distal to the renovisceral aortic segment, and at the dorsal side of the stent graft, as previously reported. 18 In addition, further stent graft modifications might allow a staged and controlled side branch flow regulation either to reduce side branch perfusion and intentionally occlude the TASP side branch in patients without SCI, or to increase the side branch and spinal perfusion with the option to reopen an occluded perfusion branch in patients with immediate or late symptoms of severe SCI. In addition, secondary TASP side branch completion should preferentially be performed by temporary side branch balloon occlusion in an awake patient under local anesthesia and/or with neurophysiological monitoring to identify early neurological deficits related to SCI. 16, 19, 23, 24 Staged procedures with secondary side branch occlusion would then be required only in those patients with pathological motor evoked responses during temporary balloon occlusion of the TASP side branch.
Further attention needs to be addressed to the time point for secondary completion of TASP side branches. It is so far unknown if the length of the TASP interval is related to the degree of expansion of the spinal cord collateral network, associated with the intended prevention of severe SCI. Furthermore, prolongation of the time interval until secondary side branch completion is performed will increase the risk of aneurysm progression and rupture, as reported for one of the patients with an aneurysm diameter <6 cm. Therefore, early secondary side branch completion within 4 weeks should be recommended in patients without a neurological deficit. In patients with persistent SCI, or who are just recovering from severe SCI, an individual recommendation has to consider the risk of aneurysm rupture after a TASP interval >4 weeks and the option for further improvement of neurological symptoms. Intraoperative balloon occlusion of the TASP side branch with additional monitoring of motor-evoked potentials might allow the identification of patients being at increased risk of SCI or those who will tolerate early side branch completion. 25 In summary, this study, which investigated the concept of TASP after bEVAR for TAAA, indicates that this approach seems to be feasible, with promising results regarding a reduced risk of severe SCI or paraplegia. Based on our current knowledge, and considering the increased risk of aneurysm rupture, secondary TASP side branch completion should be performed early (after days or at least within 4 weeks) in patients without SCI with an option for an extended TASP interval for patients with paraplegia or those recovering from SCI. Intraoperative neurological monitoring to identify early changes related to SCI, side branch completion under local anesthesia and new stent graft modifications regulating side branch aneurysm sac perfusion might further improve this concept. 
